250 Verified Questions
NSG 527 Midterm Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+.
100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation resource for NSG 527 (Psychopathology, Theories, & Advanced
Clinical Modalities) at Wilkes University features 250 verified questions and answers. Designed to
align with the 2026/2027 curriculum, it covers essential topics in psychopathology, theoretical
frameworks, and advanced clinical interventions. Each question is accompanied by a detailed rationale,
ensuring a deep understanding of key concepts. This document is an indispensable tool for achieving a
top score on the midterm exam.
Key Features:
Psychopathology: DSM-5-TR criteria, symptom clusters, and differential diagnoses
Theoretical Foundations: Psychodynamic, cognitive-behavioral, humanistic, and biological perspectives
Advanced Clinical Modalities: Evidence-based psychotherapies, pharmacotherapy, and integrative approaches
Assessment and Diagnosis: Clinical interviewing, diagnostic tools, and case formulation
Ethical and Cultural Considerations: Informed consent, confidentiality, and culturally competent care
Treatment Planning: Goal setting, intervention selection, and outcome evaluation
Updates for 2026:
- Updated to reflect 2026/2027 academic year guidelines and DSM-5-TR revisions
- Incorporated latest evidence-based practice recommendations for psychopathology and treatment
- Added new questions on telehealth modalities and digital mental health interventions
- Revised rationales to include current research and clinical case examples
- Enhanced coverage of cultural and diversity issues in psychopathology and treatment
Abstract:
This document provides a rigorous review of NSG 527 course content, focusing on psychopathology, theoretical
orientations, and advanced clinical modalities. It includes 250 verified exam questions with detailed answers and
rationales, designed to facilitate mastery of complex psychiatric concepts. The material is organized by content
area, with each section reflecting the latest DSM-5-TR criteria and evidence-based practices. Emphasis is placed
on differential diagnosis, treatment planning, and ethical decision-making within a multicultural framework. This
resource is essential for nursing students preparing for the Wilkes University midterm examination, offering a
structured approach to study and self-assessment. The questions mirror the format and difficulty of the actual
exam, ensuring comprehensive preparation. By engaging with this material, students will develop critical thinking
skills necessary for advanced clinical practice. The document also includes updates on emerging trends in
psychopharmacology and psychotherapy integration.
Keywords:
NSG 527 midterm exam, psychopathology, theories of psychotherapy, advanced clinical modalities, DSM-5-TR,
evidence-based practice, Wilkes University, nursing exam prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining why it is correct, along with
explanations for incorrect options. Rationales include references to DSM-5-TR criteria, theoretical principles, and
clinical guidelines. This format reinforces learning and helps students understand the reasoning behind each
answer.
Compliance Checklist:
Page 1
, Content aligns with NSG 527 course syllabus and learning objectives
Questions reflect current DSM-5-TR diagnostic criteria
Answers incorporate evidence-based practice guidelines
Rationales address common misconceptions and differential diagnoses
Material is updated for the 2026/2027 academic year
Includes ethical and cultural considerations in clinical scenarios
Content Area Overview:
Content Area Questions Key Topics Weight
Psychopathology 1-60 DSM-5-TR diagnostic criteria, symptom 24%
presentation, epidemiology, comorbidity
Theoretical Foundations 61-120 Psychodynamic, cognitive-behavioral, 24%
humanistic, biological, and integrative
theories
Advanced Clinical Modalities 121-180 Evidence-based psychotherapies, 24%
pharmacotherapy, telehealth, integrative
treatment
Assessment and Diagnosis 181-210 Clinical interviewing, diagnostic tools, case 12%
formulation, differential diagnosis
Ethical and Cultural 211-230 Informed consent, confidentiality, cultural 8%
Considerations competence, ethical dilemmas
Treatment Planning and 231-250 Goal setting, intervention selection, 8%
Outcome Evaluation monitoring progress, evidence-based
outcomes
Page 2
,Q1. A 35-year-old individual presents with a 6-month history of excessive worry, muscle tension, and
difficulty concentrating, with no identifiable trigger. Symptoms have persisted despite lifestyle modifications.
Which neurobiological finding is most consistent with this presentation?
A. Increased amygdala reactivity to threat cues and decreased prefrontal cortical inhibition
B. Hypoactivity of the hypothalamic-pituitary-adrenal (HPA) axis with low cortisol levels
C. Elevated dopamine D2 receptor occupancy in the mesolimbic pathway
D. Reduced gamma-aminobutyric acid (GABA) levels in the basal ganglia
Correct Answer: A. Increased amygdala reactivity to threat cues and decreased prefrontal cortical inhibition
Rationale: Generalized anxiety disorder is associated with hyperactive amygdala and impaired top-down
regulation by the prefrontal cortex. Option B is incorrect because GAD typically involves HPA axis hyperactivity
with elevated cortisol. Option C is more relevant to psychosis. Option D is not a consistent finding; GABA deficits
are more linked to panic disorder.
Why Wrong:
B - HPA axis hypoactivity and low cortisol are features of atypical depression or PTSD, not GAD.
C - Elevated dopamine D2 receptor occupancy is associated with schizophrenia, not anxiety disorders.
D - Reduced GABA in the basal ganglia is not a hallmark of GAD; GABA deficits in the amygdala and
cortex are more relevant.
Reference: Stahl, S. M. (2021). Stahl's Essential Psychopharmacology (5th ed.), Chapter 8.
Q2. In the context of cognitive-behavioral therapy for obsessive-compulsive disorder, which mechanism is
hypothesized to underlie the therapeutic effect of exposure and response prevention?
A. Strengthening of safety-seeking behaviors through operant conditioning
B. Extinction of conditioned fear responses via inhibitory learning
C. Reconsolidation of traumatic memories through imaginal exposure
D. Cognitive restructuring of maladaptive schemas about responsibility
Correct Answer: B. Extinction of conditioned fear responses via inhibitory learning
Rationale: Exposure and response prevention (ERP) promotes extinction learning, where new inhibitory
associations are formed that compete with the original fear memory. Option A is the opposite; ERP discourages
safety behaviors. Option C is more relevant to PTSD. Option D is a component of cognitive therapy but not the
primary mechanism of ERP.
Why Wrong:
A - Safety-seeking behaviors maintain anxiety; ERP aims to reduce them, not strengthen them.
C - Reconsolidation is targeted in memory updating interventions, not standard ERP for OCD.
D - Cognitive restructuring is part of CT, but the mechanism of ERP is extinction, not schema change.
Reference: Abramowitz, J. S., & Jacoby, R. J. (2015). Obsessive-Compulsive Disorder: A Cognitive-Behavioral
Approach.
Q3. A patient with a history of recurrent major depressive episodes is started on an antidepressant that
inhibits the reuptake of serotonin and norepinephrine. After four weeks, the patient reports improved mood
but also new-onset insomnia and sexual dysfunction. Which pharmacodynamic property is most likely
responsible for these side effects?
A. Antagonism of histamine H1 receptors leading to sedation and weight gain
B. Activation of postsynaptic 5-HT2A receptors in the prefrontal cortex and spinal cord
C. Inhibition of CYP2D6 leading to elevated levels of the parent drug
D. Downregulation of beta-adrenergic receptors over time
Correct Answer: B. Activation of postsynaptic 5-HT2A receptors in the prefrontal cortex and spinal cord
Rationale: SNRIs (e.g., venlafaxine, duloxetine) increase serotonin, which activates 5-HT2A receptors, causing
insomnia and sexual dysfunction. Option A is more typical of sedating antidepressants like mirtazapine. Option C is
a pharmacokinetic interaction, not a direct cause of these side effects. Option D is a proposed mechanism of
Page 3
, antidepressant efficacy, not side effects.
Why Wrong:
A - H1 antagonism causes sedation, not insomnia; weight gain is also associated with H1 blockade.
C - CYP2D6 inhibition can increase drug levels but does not directly cause insomnia or sexual dysfunction.
D - Beta-receptor downregulation is associated with therapeutic response, not acute side effects.
Reference: Lehne, R. A. (2026). Pharmacology for Nursing Care (12th ed.), Chapter 32.
Q4. Which theoretical perspective posits that borderline personality disorder (BPD) arises from an
invalidating environment combined with biological vulnerability to emotional dysregulation, leading to
deficits in distress tolerance and interpersonal effectiveness?
A. Dialectical behavior therapy (DBT) biosocial theory
B. Mentalization-based treatment (MBT) attachment theory
C. Transference-focused psychotherapy (TFP) object relations theory
D. Schema therapy early maladaptive schema model
Correct Answer: A. Dialectical behavior therapy (DBT) biosocial theory
Rationale: Linehan's biosocial theory specifically integrates biological emotional sensitivity with an invalidating
environment, forming the basis for DBT. Option B emphasizes attachment and mentalizing failures. Option C
focuses on splitting and primitive defenses. Option D identifies early maladaptive schemas, but not the invalidating
environment in the same way.
Why Wrong:
B - MBT theory centers on impaired mentalization due to insecure attachment, not invalidating environment.
C - TFP theory is rooted in object relations and focuses on identity diffusion and primitive defenses.
D - Schema therapy emphasizes early maladaptive schemas from unmet core needs, but not specifically the
invalidating environment as a key factor.
Reference: Linehan, M. M. (1993). Cognitive-Behavioral Treatment of Borderline Personality Disorder.
Q5. A 28-year-old individual with no prior psychiatric history presents with a two-week history of pressured
speech, decreased need for sleep, grandiosity, and excessive involvement in risky activities. Urine toxicology
is negative. Which of the following is the most appropriate first-line pharmacotherapy if the patient is not
currently on any medication?
A. Lithium carbonate with target serum level 0.6-1.2 mEq/L
B. Valproic acid loading dose 20 mg/kg/day
C. Aripiprazole 10-15 mg/day
D. Lamotrigine 25 mg/day titrated slowly
Correct Answer: A. Lithium carbonate with target serum level 0.6-1.2 mEq/L
Rationale: Lithium remains first-line for acute mania in bipolar I disorder, especially in a first episode without
contraindications. Option B (valproate) is also effective but often second-line due to side effects. Option C
(aripiprazole) is an option but not first-line monotherapy unless rapid stabilization needed. Option D (lamotrigine)
is ineffective for acute mania and used for maintenance.
Why Wrong:
B - Valproic acid is effective but not first-line due to potential teratogenicity and metabolic effects; lithium is
preferred.
C - Aripiprazole is an atypical antipsychotic that can be used, but lithium is considered first-line for classic
euphoric mania.
D - Lamotrigine is not effective for acute mania; it is indicated for maintenance and bipolar depression.
Reference: American Psychiatric Association. (2020). Practice Guideline for the Treatment of Patients With
Bipolar Disorder (2nd ed.).
Page 4